AI, Data Science & Cloud Certificates from Google, IBM & Meta — 40% Off
One plan covers every Professional Certificate on Coursera. 40% off Coursera Plus Annual.
Unlock All Certificates
Explore a 34-minute webinar presented by Dr. Xiangjun Kong, Principal Scientist at Neogene Therapeutics, on the development of a T cell engineering platform for individualized neoantigen-specific TCR therapy. Gain insights into a promising new immunotherapy approach involving adoptive transfer of T cell receptor (TCR)-edited T cells targeting cancer neoantigens. Learn about the high-throughput, patient-specific platform developed to identify neoantigen-reactive TCRs. Discover Dr. Kong's extensive research background in functional screening, genome editing technologies, and novel targeted and immune therapy strategies for cancer. Understand the potential impact of this innovative approach on personalized cancer treatment.
